Australia's Nova Eye Medical jumps on upbeat FY27 earnings guidance

Nova Eye Medical

29/07/2026 04:34

** Shares of Nova Eye Medical EYE.AX rise as much as 12.5% to A$0.135, set to clock its steepest intraday pct rise since July 21
** Medical tech co sees FY27 sales, excluding China, between $26 million and $31 million and expects to generate to positive EBITDA
** Posts total sales for the year of $23.7 million, up 26% 
** About 871,000 shares change hands, 3.5 times the 30-day avg 
** Stock is down 2% YTD, including the session's moves
     

 (Reporting by Anjali Singh in Bengaluru)
 ((anjali.singh2@thomsonreuters.com;))